Among 51 patients with a PD-L1 tumor proportion score (TPS) of ≥50%, 32 achieved a confirmed response, resulting in an ORR of 63% and a DCR of 84%, with the median PFS not reached (22). This evidence concerns the gene CD274 and neoplasm.